Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients.
Parissis
John T
JT
Farmakis
Dimitrios
D
Bistola
Vassiliki
V
Adamopoulos
Stamatios
S
Kremastinos
Dimitrios Th
DT
D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage / Q000627:therapeutic use*; D018579:Patient Selection; D011724:Pyridazines / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000077464:Simendan
D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan